Anti-TAPT1 monoclonal antibody

Pre-made anti-TAPT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TAPT1/TAPT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1883-Ab-1/ GM-Tg-hg-IP1883-Ab-2Anti-Human TAPT1 monoclonal antibodyHuman
GM-Tg-rg-IP1883-Ab-1/ GM-Tg-rg-IP1883-Ab-2Anti-Rat TAPT1 monoclonal antibodyRat
GM-Tg-mg-IP1883-Ab-1/ GM-Tg-mg-IP1883-Ab-2Anti-Mouse TAPT1 monoclonal antibodyMouse
GM-Tg-cynog-IP1883-Ab-1/ GM-Tg-cynog-IP1883-Ab-2Anti-Cynomolgus/ Rhesus macaque TAPT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1883-Ab-1/ GM-Tg-felg-IP1883-Ab-2Anti-Feline TAPT1 monoclonal antibodyFeline
GM-Tg-cang-IP1883-Ab-1/ GM-Tg-cang-IP1883-Ab-2Anti-Canine TAPT1 monoclonal antibodyCanine
GM-Tg-bovg-IP1883-Ab-1/ GM-Tg-bovg-IP1883-Ab-2Anti-Bovine TAPT1 monoclonal antibodyBovine
GM-Tg-equg-IP1883-Ab-1/ GM-Tg-equg-IP1883-Ab-2Anti-Equine TAPT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1883-Ab-1/ GM-Tg-hg-IP1883-Ab-2; GM-Tg-rg-IP1883-Ab-1/ GM-Tg-rg-IP1883-Ab-2;
GM-Tg-mg-IP1883-Ab-1/ GM-Tg-mg-IP1883-Ab-2; GM-Tg-cynog-IP1883-Ab-1/ GM-Tg-cynog-IP1883-Ab-2;
GM-Tg-felg-IP1883-Ab-1/ GM-Tg-felg-IP1883-Ab-2; GM-Tg-cang-IP1883-Ab-1/ GM-Tg-cang-IP1883-Ab-2;
GM-Tg-bovg-IP1883-Ab-1/ GM-Tg-bovg-IP1883-Ab-2; GM-Tg-equg-IP1883-Ab-1/ GM-Tg-equg-IP1883-Ab-2
Products NameAnti-TAPT1 monoclonal antibody
Formatmab
Target NameTAPT1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TAPT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1883-Ag-1Recombinant multi-species TAPT1/ CMVFR/ OCLSBG protein


    Target information

    Target IDGM-IP1883
    Target NameTAPT1
    Gene ID202018,231225,305386,714712,488815,101081135,615598,100068801
    Gene Symbol and Synonyms4932414K18Rik,CMVFR,OCLSBG,RGD1309656,TAPT1
    Uniprot AccessionQ6NXT6
    Uniprot Entry NameTAPT1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000169762
    Target ClassificationN/A

    The target: TAPT1, gene name: TAPT1, also named as CMVFR, OCLSBG. This gene encodes a highly conserved protein that localizes to the centrosome and/or ciliary basal body. Mutations in this gene disrupt Golgi morphology and trafficking and normal primary cilium formation and these mutations are congenitally manifested by severe undermineralization of the intra-uterine skeleton. A mutation in the mouse ortholog of this gene results in homeotic, posterior-to-anterior transformations of the axial skeleton which are similar to the phenotype of mouse homeobox C8 gene mutants. In mouse, this gene is thought to function downstream of homeobox C8 to transduce extracellular patterning information during axial skeleton development. [provided by RefSeq, Jan 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.